Skip to content

Effect of the test food intake on quality of life in participants with an advanced immunosenescence: A randomized, placebo controlled, single blind, parallel group dose-finding study

Effect of the test food intake on quality of life in participants with an advanced immunosenescence: A randomized, placebo controlled, single blind, parallel group dose-finding study - Effect of the test food intake on quality of life in participants with an advanced immunosenescence: A dose-finding study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048415
Enrollment
92
Registered
2023-12-31
Start date
2022-07-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

High-dose test food ingestion for 12 consecutive weeks Medium-dose test food ingestion for 12 consecutive weeks Low-dose test food ingestion for 12 consecutive weeks Placebo ingestion for 12 consecuti

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese male and female participants, 40 to 69 years of age. 2. POMS2-AS T score of Fatigue-Inertia >=50, and Vigor-Activity <=50. 3. Relatively high percentage of CD8+ T cells with high senescence-associated beta-galactosidase (SA-beta-gal) activity. 4. Have ability to consent.

Exclusion criteria

Exclusion criteria: 1. Undergone surgical resection of the gastrointestinal tract (Not including appendectomy). 2. Have disease that requires constant medication, or those have a serious medical history that requires medication. 3. Having or had treatment for or diagnosed as autoimmune diseases. 4. Having or had mental illness, chronic fatigue syndrome or sleep disturbance. 5. Diagnosed or suspected as sleep apnea syndrome. 6. Under sleep, stress, and/or fatigue treatment. 7. Night and day shift worker or manual laborer. 8. Regularly taking or planning to take medicine, supplements, FOSHU, and/or food which may affect the results during the study. 9. Possible allergic response related to the study. 10. Is or expected to be pregnant, breastfeeding or desiring to be pregnant during the study period. 11. Excessive drinking habits. 12. Planning to travel abroad during the study period, or planning to go on domestic business trips or domestic trips for more than 7 consecutive days during the study period. 13. Participating in other clinical studies at the beginning of the present study. 14. Judged by the investigator to be inappropriate candidates.

Design outcomes

Primary

MeasureTime frame
T scores of the Profile of Mood States 2nd Edition Adult Short Form (POMS2-AS) (Japanese version)

Secondary

MeasureTime frame
Immunosenescence markers, Anti-Aging QOL Common Questionnaire, MOS 36-Item Short-Form Health Survey version 2 acute version (Japanese version), Pittsburgh Sleep Quality Index (Japanese version)

Countries

Japan

Contacts

Public ContactReiko Naito

Kenkoin Medical Corporation Foundation Kenkoin Clinic

reiko-naito@kenkoin.jp03-3573-1153

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026